Stock Research for DYN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

DYN Stock Chart & Research Data

The DYN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the DYN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


DYN Due diligence Resources & Stock Charts

The DYN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View DYN Detailed Price Forecast - CNN Money CNN View DYN Detailed Summary - Google Finance
Yahoo View DYN Detailed Summary - Yahoo! Finance Zacks View DYN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View DYN Trends & Analysis - Trade-Ideas Barrons View DYN Major Holders - Barrons
NASDAQ View DYN Call Transcripts - NASDAQ Seeking View DYN Breaking News & Analysis - Seeking Alpha
Spotlight View DYN Annual Report - CompanySpotlight.com OTC Report View DYN OTC Short Report - OTCShortReport.com
TradeKing View DYN Fundamentals - TradeKing Charts View DYN SEC Filings - Bar Chart
WSJ View Historical Prices for DYN - The WSJ Morningstar View Performance/Total Return for DYN - Morningstar
MarketWatch View the Analyst Estimates for DYN - MarketWatch CNBC View the Earnings History for DYN - CNBC
StockMarketWatch View the DYN Earnings - StockMarketWatch MacroAxis View DYN Buy or Sell Recommendations - MacroAxis
Bullish View the DYN Bullish Patterns - American Bulls Short Pains View DYN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View DYN Stock Mentions - StockTwits PennyStocks View DYN Stock Mentions - PennyStockTweets
Twitter View DYN Stock Mentions - Twitter Invest Hub View DYN Investment Forum News - Investor Hub
Yahoo View DYN Stock Mentions - Yahoo! Message Board Seeking Alpha View DYN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for DYN - SECform4.com Insider Cow View Insider Transactions for DYN - Insider Cow
CNBC View DYN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for DYN - OTC Markets
Yahoo View Insider Transactions for DYN - Yahoo! Finance NASDAQ View Institutional Holdings for DYN - NASDAQ


Stock Charts

FinViz View DYN Stock Insight & Charts - FinViz.com StockCharts View DYN Investment Charts - StockCharts.com
BarChart View DYN Stock Overview & Charts - BarChart Trading View View DYN User Generated Charts - Trading View




Latest Financial News for DYN


Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer
Posted on Wednesday March 27, 2024

WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that it has granted an inducement equity award to its newly appointed President and Chief Executive Officer, John G. Cox. The award was approved by the Compensation Committee of Dyne and was made as an inducement material to Mr. Cox’s acce


Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
Posted on Wednesday March 27, 2024

WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that Wildon Farwell, M.D., MPH, chief medical officer, and Oxana Beskrovnaya, Ph.D., chief scientific officer, are scheduled to participate in a fireside chat during the Cantor Virtual Muscular Dystrophy Symposium on Tuesday, April 2, 2024


Dyne Therapeutics Announces CEO Transition
Posted on Monday March 25, 2024

John Cox John Cox, President and CEO of Dyne Therapeutics - John Cox, Industry Leader with Global Experience in Rare Disease Commercialization, Joins Dyne as President and CEO - WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the appointment of John Cox as president, chief executive off


Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
Posted on Wednesday March 13, 2024

WALTHAM, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at the Stifel 2024 Virtual CNS Days on Wednesday, March 20, 2024 at 8:30 a.m. ET. A live webcast will be available in the Investors & Media section of Dyne’s website at https:/


Stock Market & Investing Books

Enter a stock symbol to view the stock details.